| Product NDC: | 0078-0635 |
| Proprietary Name: | Signifor |
| Non Proprietary Name: | pasireotide |
| Active Ingredient(s): | .9 mg/mL & nbsp; pasireotide |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0078-0635 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA200677 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20121214 |
| Package NDC: | 0078-0635-20 |
| Package Description: | 60 PACKAGE in 1 BOX (0078-0635-20) > 6 AMPULE in 1 PACKAGE (0078-0635-06) > 1 mL in 1 AMPULE (0078-0635-61) |
| NDC Code | 0078-0635-20 |
| Proprietary Name | Signifor |
| Package Description | 60 PACKAGE in 1 BOX (0078-0635-20) > 6 AMPULE in 1 PACKAGE (0078-0635-06) > 1 mL in 1 AMPULE (0078-0635-61) |
| Product NDC | 0078-0635 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pasireotide |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20121214 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | PASIREOTIDE |
| Strength Number | .9 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |